Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Norepinephrine for Hepatic Arterial Blood Flow Modulation in HCC
NCT02472249Phase 4Completed
- Sponsor
- University Health Network
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norepinephrine in hepatocellular carcinoma (HCC), sponsored by University Health Network. Started Jan 2016; status: completed.
02
Drugs
norepinephrine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02472249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472249.